Company / Book Value per Share
Zenas BioPharma, Inc. Book Value per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.794
FY2025
5-year range
-$147.417 / $5.794
FY2023-FY2025
Trend
+104.0%
vs FY2024
Sector context
#101 of 209
Health Care
What the data says
At $5.794, Zenas BioPharma, Inc.'s book value per share ranks #101 of 209 in the Health Care sector. Improved from -$147.417 to $5.794 over the past 2 years.
Based on SEC 10-K filings.
$5.794 in FY2025.
Improved from -$147.417 to $5.794 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#101 of 209 in Health CareTop 48% of 209This company $5.794 Sector average $189.406
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 104.0% year-over-year.
- Ranks #101 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.794 | +104.0% |
| FY2024 | -$143.146 | +2.9% |
| FY2023 | -$147.417 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026